Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    0.00 (0.00%)
Bid:
64.50
Ask:
65.80
Spread: 1.30 (2.016%)
Market Cap: £100.37m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Director/PDMR Shareholding

28 Mar 2025 09:29

RNS Number : 6863C
Macfarlane Group PLC
28 March 2025
 

Macfarlane Group PLC

28th March 2025

 

Macfarlane Group PLC

Director / PDMR Shareholding

Macfarlane Group PLC (LON: MACF) announces that on 26th March 2025 the following persons discharging managerial responsibilities ('PDMRs') acquired ordinary shares of 25 pence each in the Company ("Shares") for nil consideration upon the maturity of the 27th March 2023 awards under the Company's 2022 Deferred Bonus Share Plan ("DBSP"), together with details of the subsequent sale of certain shares automatically arranged on their behalf in accordance with the terms of the DBSP to satisfy related income tax and national insurance liabilities:

PDMR

 

Number of Shares acquired for nil cost (including those added for in respect of dividend equivalent)

 

Number of Shares sold to satisfy income tax and national insurance

Number of Shares retained post sale

Total number of Shares held in the Company

% held of Company's issued share capital

Peter Atkinson

 

64,596

29,128

35,468

1,513,456

0.95%

Ivor Gray

 

31,357

15,397

15,960

303,324

0.19%

 

The Company has been informed that today, the Company's employee benefit trust (the "EBT") purchased 44,525 Shares at an average price of 104.50 pence per Share to help satisfy any future exercise of share options. As a result, the EBT now holds 278,640 Shares in the Company which is approximately 0.17% of the Company's issued share capital.

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Peter Atkinson

2. Ivor Gray

2

Reason for Notification

a)

Position/status

1. Chief Executive

2. Group Finance Director

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macfarlane Group PLC

b)

LEI

213800LVRYDERSJAAZ73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each in Macfarlane Group plc

GB0005518872

b)

Nature of the transaction

Settlement of award under the Company DBSP acquired for nil consideration.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. Nil

2. Nil

64,596 ordinary shares

31,357 ordinary shares

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

Nil

e)

Date of the transaction

26 March 2025

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Peter Atkinson

2. Ivor Gray

2

Reason for Notification

a)

Position/status

1. Chief Executive

2. Group Finance Director

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macfarlane Group PLC

b)

LEI

213800LVRYDERSJAAZ73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each in Macfarlane Group plc

GB0005518872

b)

Nature of the transaction

Disposals arranged by the Company's employee benefit trust to cover income tax and national insurance liabilities

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. 104.50 pence

2. 104.50 pence

 

 

29,128 ordinary shares

15,397 ordinary shares

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

e)

Date of the transaction

26 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Aleen Gulvanessian Chair

Peter Atkinson Chief Executive

Ivor Gray Finance Director

 

Spreng Thomson

Callum Spreng

Mob: 07803 970103

 

 

Notes to Editors:

· Macfarlane Group PLC has been listed on the Main Market of the London Stock Exchange plc (LSE: MACF) since 1973, with over 70 years' experience in the UK packaging industry.

· Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high-quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:

 o Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and

 o Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.

· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,000 people at 43 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.

· Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.

· In partnership with 1,700 suppliers, Macfarlane Group distributes and manufactures 600,000+ lines, supplying to a wide range of sectors, including: retail e-commerce; consumer goods; food; logistics; mail order; electronics; defence; medical; automotive; and aerospace.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDXLDDDGUI
Date   Source Headline
17th May 20192:20 pmRNSDirector/PDMR Shareholding
14th May 20193:21 pmRNSResult of AGM
14th May 201912:00 pmRNSAGM Statement
7th May 20197:00 amRNSAcquisition of Ecopac (UK) Limited
1st May 201911:35 amRNSHolding(s) in Company
4th Apr 201912:07 pmRNSAnnual Report and Notice of AGM
8th Mar 20194:26 pmRNSDirector Declaration
25th Feb 20191:15 pmRNSChange of Registered Office
21st Feb 20197:00 amRNSFinal Results
7th Jan 20192:45 pmRNSNotice of Results
4th Jan 20192:11 pmRNSHolding(s) in Company
19th Dec 20181:00 pmRNSDirector/PDMR Shareholding
14th Dec 20185:13 pmRNSDirector/PDMR Shareholding
12th Dec 201812:40 pmRNSHolding(s) in Company
10th Dec 20185:29 pmRNSHolding(s) in Company
27th Nov 201811:37 amRNSHolding(s) in Company
20th Nov 20187:00 amRNSInterim Management Statement
12th Sep 20189:22 amRNSHalf-year Report
28th Aug 20187:00 amRNSBoard Changes
23rd Aug 20187:00 amRNSHalf-year Report
20th Aug 20188:34 amRNSHolding(s) in Company
6th Jul 20189:54 amRNSNotice of Interim Results
15th May 20183:51 pmRNSResult of AGM
15th May 201812:00 pmRNSAGM Statement
4th Apr 20182:00 pmRNSAnnual Report and Notice of AGM
19th Mar 20181:14 pmRNSHolding(s) in Company
22nd Feb 20187:00 amRNSFinal Results
22nd Jan 201810:23 amRNSNotice of Results
8th Jan 20188:30 amRNSAppointment of Non-Executive Director
16th Nov 20177:00 amRNSInterim Management Statement
8th Nov 20175:54 pmRNSHolding(s) in Company
19th Oct 20172:53 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSDirectorate Change
26th Sep 201710:05 amRNSHolding(s) in Company
25th Sep 20178:22 amRNSHolding(s) in Company
21st Sep 201712:23 pmRNSCompletion of Acquisition and Total Voting Rights
21st Sep 20179:33 amRNSHolding(s) in Company
21st Sep 20178:16 amRNSHolding(s) in Company
18th Sep 201712:42 pmRNSResult of Oversubscribed Placing
18th Sep 20177:00 amRNSConditional acquisition and £8 million placing
12th Sep 201711:10 amRNSHalf-year Report
24th Aug 20177:00 amRNSHalf-year Report
14th Jul 20179:03 amRNSNotice of Results
6th Jul 20178:52 amRNSHolding(s) in Company
4th Jul 20179:06 amRNSHolding(s) in Company
3rd Jul 201710:19 amRNSDirector Declaration
9th May 20174:50 pmRNSResult of AGM
9th May 201712:00 pmRNSAGM Statement
3rd Apr 20179:46 amRNSAnnual Financial Report
10th Mar 20171:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.